cancer

Spot celebrities at the third annual Athletes vs. Cancer football game, hosted by Matt Barnes and Snoop Dogg, on Sunday, Aug. 23, 6 p.m. at UCLA's Drake Stadium.

Elisa Long, an expert in probability and statistics at the UCLA Anderson School of Management, wrote a column that appeared in the Washington Post about how statistics helped guide her through life, death and 'The Price is Right.'

UCLA researchers found that a subset of ovarian cancer cells that don’t produce the CA125 protein biomarker, used to test for ovarian cancer, have an enhanced ability to repair their DNA and resist programmed cell death.

The treatment uses a chemical to block an RNA molecule that’s typically found in high levels in people with ulcerative colitis.

With less of the protein, called p53, older epithelial cells have a hard time maintaining the integrity of their genetic material when they encounter carcinogens, which allows cancer to develop.

Results of the study provide evidence that drugs used to treat diabetes could be used to reduce tumor growth in pancreatic and prostate cancers.

Dr. Rajan Kulkarni, UCLA Jonsson Comprehensive Cancer Center member and clinical instructor in the division of dermatology, has been granted a Young Investigator Award of $75,000 on behalf of the Melanoma Research Alliance.

Scientists from UCLA and City of Hope have become the first to inhibit the mechanism of a protein that regulates a key process that causes cancer to grow.

Doctors are encouraged to see that a growing number of cancer patients are being snatched from the precipice by novel immunotherapy treatments.

Newer, more targeted method, called partial breast irradiation, takes less time to complete and is less likely to expose vital organs to potentially harmful radiation.

Revlon CEO Lorenzo Delpani, chairman Ronald O. Perelman and global brand ambassador Halle Berry announced the gift at an event honoring Slamon, a member of the UCLA Jonsson Comprehensive Cancer Center.

The researchers say that women with a high risk for breast cancer recurrence benefit by having chemotherapy as part of their treatment, but for those at low risk, chemo has no added value.

The team, led by Dr. Joanne Weidhaas, found that acute estrogen withdrawal was associated with breast cancer in women with the KRAS-variant.

The 20th annual event benefited UCLA’s Jonsson Comprehensive Cancer Center.

The results “have the potential to substantively change the way that lung cancer is treated,” said Dr. Edward Garon, a member of UCLA’s Jonsson Comprehensive Cancer Center.

Developed under the leadership of UCLA’s Dr. Antoni Ribas, the drug has signaled a paradigm shift in the way melanoma is treated.

Wealthier women living in communities with larger income gaps are most likely to get a test that can help determine the best way to treat early-stage breast cancer.

Dr. Dennis Slamon, director of the Revlon/UCLA Women’s Cancer Research Program and director of clinical and translational research at the Jonsson Cancer Center, will appear in a three-part, six-hour series on PBS, "Cancer: The Emperor of All Maladies."

New treatment platform may solve some of the problems of treating pancreas cancer with chemotherapy.

The combination of two cancer-targeted therapies and immunotherapy helps a person’s immune system attack cancerous tumors and does so with fewer side effects.

A series of mental training exercises has been shown to help mitigate the effects of “chemo brain,” which affects up to 35 percent of women after their treatments for breast cancer.

The doctors developed a predictive “calculator” called a nomogram after analyzing 30 years’ worth of data from liver transplants for people with liver cancer.

On March 9, Apple announced the launch of Share the Journey, a mobile app that UCLA’s Dr. Patricia Ganz helped develop.

Funding from the Hirshberg Foundation has elevated the UCLA center to one of the nation’s premier comprehensive programs for pancreatic cancer and diseases.

Radiation therapy is the most common treatment for men with prostate cancer, but it may not always be worthwhile.